Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dentispray is an approved topical dental anesthetic solution developed and marketed by Laboratorios Viñas. The formulation contains 5% benzocaine (50 mg/ml) as its active ingredient. It functions as a local anesthetic by blocking sensory receptors in the oral mucous membranes, providing rapid symptomatic relief of toothaches, dental pain, and gum discomfort. Delivered via an oral spray with a dosing pump and applicator cannula, the product typically takes effect within 30 to 60 seconds, with the anesthetic effect lasting approximately 10 to 15 minutes. It is indicated for use in adults and children over 2 years of age and is available as an over-the-counter medication in Spain.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Dentispray.